| 摘要 |
<p>Compositions consisting of C1 inhibitor muteins having biological activity similar to C1 inhibitor, but with enhanced resistance to proteolytic cleavage thus rendering such muteins suitable as anti-inflammatory agents, preferably for the treatment or prevention of sepsis.</p> |
